Distant metastasis remains a major obstacle to successful breast cancer treatment. Anoikis (detachment-induced apoptosis) has been suggested to act as a barrier to metastasis. Here, we report that miR-200a, functioning as an anoikis suppressor, promotes anoikis resistance by targeting YAP1 and subsequently leads to distant metastasis in breast cancer. Our study also provides evidence that overexpression of miR-200a might affect the prognosis of breast cancer patients. Therefore, understanding the mechanism and function of miR-200a as a pro-metastatic miRNA may provide new therapeutic opportunities for breast cancer treatment.
Introduction:
Breast cancer is the second-leading cause of cancer-related death in women. Exciting progress has been made in the systemic therapy and earlier diagnosis of breast cancer (1) . However, distant metastases remain a major obstacle in the successful treatment of breast cancer, and the mechanism of breast cancer metastasis is still not completely understood (2, 3) .
Emerging evidence indicates that the expression of several microRNAs (miRNAs), including miR-10b, miR-335 and miR-31, is altered in the metastatic cascade (4) (5) (6) . The miR-200 family has multiple functions in regulation of cancer stem cells, chemosensitivity and apoptosis (7) (8) (9) (10) . It was recently reported that the miR-200a suppress the epithelial-mesenchymal transition (EMT), the initiating step of metastasis (11) (12) (13) (14) . Interestingly, miR-200 family promotes breast cancer metastasis to lung in an isogenic model (15, 16) . miRNAs are known to target the metastatic cascade and enhance both pro-and anti-metastatic signals, especially in the early and late steps of tumor metastasis (4, 6, 17) .
Anoikis is an important barrier to distant metastasis. Resistance to anoikis enhances the survival of cancer cells during systemic circulation, thereby facilitating secondary tumor formation in distant organs (14, 15) . miR-200a, a member of the miR-200 family, involves in multiple steps of metastasis, such as suppressing EMT and promoting the lung metastasis. However, the function of miR-200a on the regulation of anoikis remains unknown. YAP1 (Yes-associated protein 1), a key node of the Hippo signaling pathway, has been implicated as a tumor suppressor in breast (18) . Binding of Tyr-357 phosphorylated YAP1 with the PY motif allows p73 to escape Itch-mediated ubiquitination (19) (20) (21) . Loss function of YAP1 was reported to protect cells from anoikis (18) . In this study, we identifed a new role of miR-200a in anoikis in breast cancer and confirmed that YAP1 is a novel target of miR-200a. miR-200a induced anoikis resistance was phenocopied by knockdown of YAP1. Furthermore, ectopic expression of miR-200a promoted both anoikis resistance and metastasis of human breast cancer cells in animal models. In summary, we combine experimental and clinical studies to establish a role for miR-200a in anoikis resistance. We show that, by targeting YAP1, miR-200a allows cells to evade anoikis and embark on a metastasis spread. 6 analysis. The normalized expression of each sample was designated as CT and obtained by dividing the CT value of miR-200a by the U6 CT of the same sample. The relative amount of miRNA or mRNA in each sample was calculated using the comparative CT method. The results are presented as fold change of expression in cells or cancer tissues.
Anoikis assay
Anoikis was induced by polyHEMA (Sigma, St. Louis, MI, USA) culture. A solution containing 20 mg/ml polyHEMA in 95% ethanol was made, and 0.95 ml/mm2 of this solution was pipetted into 35-mm wells. The plates were allowed to sit, partially covered, until the ethanol evaporated and the poly-HEMA had solidified. Periodically, the plates were rocked by hand to help ensure even coating. Prior to use, the wells were washed twice with phosphate-buffered saline (PBS) and once with DMEM to remove residual ethanol. In all, 10 5 cells of each line, suspended in 2 ml DMEM with 10% FBS, were incubated in the polyHEMA-coated wells for 48 hours in a humidified (37℃, 5% CO2) incubator. After incubation, the cells were used for further analyses.
Apoptosis and colony formation assays of cells treated in suspension culture
Following induction of anoikis for 48 hours, caspase-3 activity was measured using the Caspase-Glo 3/7 assay kit (Promega) according to the manufacturer's instructions. Apoptosis was detected by FITC-Annexin V/propidium iodide (PI) double staining (Invitrogen). After washing twice with PBS, cells were labeled with FITC-Annexin V and PI for 10 min in the dark at room temperature, and cellular fluorescence was measured using a FACScan flow cytometer (Becton Dickinson). Each experiment was performed in triplicate. After suspension culture, cells were seeded into normal plates at a density of 2000 cells/100-mm2 dishes. For colony formation assays, plates were incubated for 2 weeks, and the resulting colonies were stained with crystal violet and counted.
Animals studies
MDA-MB-231 cells were transfected with synthetic hsa-mir-200a, YAP1 siRNA, or scrambled RNA and then labeled with 1,1'-Dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI, Invitrogen). Labeled cells were resuspended in culture medium at a concentration of 107 cell/ml and injected into the center of the yolk sac of transgenic fli:EGFP zebrafish (25 embryos/group, and 100 cells/embryo). One and three days after injection, DiI-labeled MDA-MB-231 cells were detected in green fluorescent protein (GFP)-labeled vessels using a fluorescence microscope, and surviving cells were counted in the tail vein (22) . Cell-Injected zebrafish were examined with Olympus BX61/SZX12 microscopes and photographed with a DP70 digital camera. Images were processed using Adobe Photoshop software. The data were derived from three replicated experiments. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on January 22, 2013; DOI: 10.1158/1078-0432.CCR- animals were injected with 100 µl of each cell line. In all experiments, the cells were introduced via tail vein injection. The animals were sacrificed and autopsied 3 weeks after injection. Metastasis was assessed by macroscopic observation of the major organs for secondary tumors and confirmed by histology. All animal experiments were performed with approval from the Shanghai Medical Experimental Animal Care Commission.
Statistical analysis
Data were shown as mean ± SEM unless otherwise noted. Statistical significance was analyzed by the unpaired Student's t test, and P < 0.05 was considered to be statistically significant. 
YAP1 is negatively regulated by miR-200a
To identify the miR-200a targets we performed an in silico search using Targetscan, MiRanda, and Diana (24) (25) (26) (27) . Cytoscape was used to find an intersection between genes that regulate the apoptotic processes (GO: 0042981) and predicted target genes of miR-200a ( Fig. 2A) (28, 29) . Among the potential targets which were listed in Supplementary Table S2, 5 candidate genes  (TGFB2, TIAM1 , FOXA1, YAP1, and ITSN1) were selected. We carried out colony formation assay to screen the genes. YAP1 attracted our attention because it mostly promoted colony formation after suspension culture. ( Supplementary Fig. S3 ). YAP1 expression was also reported lost in human breast tumors (18) .
To confirm YAP1 is a target of miR-200a, 3'-UTR of the YAP1 gene was cloned into the Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on January 22, 2013; DOI: 10.1158/1078-0432.CCR- luciferase construct psiCHECK2 ( Fig. 2B ). Luciferase assay revealed that miR-200a significantly reduced the activity of the luciferase reporter gene fused to the YAP1 3'-UTR by 52.5% ± 4.9% compared to miR-Ctrl in HEK293T cells. Intriguingly, miR-200a did not decrease the luciferase activity of a mutant construct that contained substitutions at three nucleotides within the miR-200a binding site ( Fig. 2C) . In contrast, when the wild-type reporter was co-transfected with the antagomiR-200a, the relative luciferase activity of the reporter was significantly enhanced (P < 0.01) ( Fig.2D ). These results suggested that YAP1 was a direct target of miR-200a. Furthermore, we found that transfection with the miR-200a mimic caused a 60% reduction of YAP1 protein expression in MDA-MB-231 cells (Fig. 2C ). In contrast, suppression of miR-200a with antagomiR-200a increased YAP1 protein expression in MCF-7 cells (Fig. 2D ). These data indicate that miR-200a directly targets the 3'-UTR of YAP1 to repress the expression of YAP1 protein.
miR-200a suppresses anoikis by targeting YAP1
We next investigated the correlation between miR-200a and YAP1 expression in breast cancer cell lines. Four among seven cell lines expressed high levels of miR-200a presented undetectable or low-levels of YAP1. Two cell lines (MDA-MB-231 and ZR-75-30) that expressed low levels of miR-200a expressed high levels of YAP1 ( Fig. 3A) . To further explore the effect of YAP1 on suspension-induced apoptosis, MDA-MB-231 and ZR-75-30 cells were transfected with YAP1 siRNA followed treated with 48 hours of suspension culture, then replated, and cultured under normal conditions. Both cell lines exhibited increased colony formation ( Supplementary Fig. S1A , B).
Because YAP1 is a key modulator of p73, which regulates pro-apoptotic genes, we examined caspase 3 cleavages and caspase 3/7 activity in YAP1 siRNA transfected cells. The data showed knockdown of YAP1 inhibited caspase-3 cleavage in both MDA-MB-231 and ZR-75-30 cells ( Fig.  3B ) and the caspase 3/7 activity also repressed by YAP1 siRNA in those cells. Furthermore, we examined whether the expression of noxa, bax, and Bim, three pro-apoptotic proteins, was affected by miR-200a in breast cancer cell lines (19, (30) (31) (32) . Western blotting analysis revealed that basal levels of p73, noxa, bax, and Bim were reduced following transfection with miR-200a and YAP1 siRNA in MDA-MB-231 and ZR-75-30 cells treated in suspension culture (Fig. 3D ). These data suggested that miR-200a targeting of YAP1 suppresses the pro-apoptotic protein expression and allows the cells to evade anoikis.
Transfection of miR-200a promoted in vivo breast cancer cell metastasis in zebrafish and mouse models
To analyze the in vivo effect of miR-200a on tumor cell metastasis, transgenic fli:EGFP zebrafish embryos with GFP-labeled blood vessels were prepared as an animal model. The transparent nature of zebrafish embryos allows visualization tumor cell dissemination in living fish. Immune privilege of zebrafish embryos facilitates implantation of mammalian tumor cells (22, 33) . MDA-MB-231 cells were transfected with miR-200a mimic or YAP1 siRNA, and MCF-7 cells were transfected with antagomiR-200a or antagomiR-Ctrl. After 48 hours, the transfected cells were labeled with DiI, and injected into the abdomen of zebrafish embryos. After injection, cells that seeded in the blood vessels of the zebrafish were detected, and zebrafish embryos containing metastatic cells were counted at 24 hour, and 72 hour separately. ( Fig. 4A Table S3 ). Cells transfected with the YAP1 siRNA or miR-200a mimic were seeding in nearly 75% injected zebrafish embryos, respectively. However, control MDA-MB-231 cells were observed in 40%. The metastatic cells in the tail vessels were also counted ( Fig. 4B ). Approximately 40% of miR-200a mimic or YAP1 siRNA transfected cells were able to seed in the tail vein, but only 20% of the control transfected cells could do so (supplementary Table S4 ). In addition, MCF-7 antagomiR-200a transfected MCF-7 cells showed an obvious decrease of survival cells in zebrafish tail vein compared with antagomiR-Ctrl transfected cells (Fig. 4A, B) .
To further examine the effects of miR-200a on metastasis in a mouse model, the metastatic potential of stably miR-200a and scramble transfected MDA-MB-231 cells were injected into tail vein in BALB/c nude mice. Intravenous injection of pMR-miR-200a-transfected MDA-MB-231 cells labeled with GFP induced marked lung colony formation in vivo, whereas MDA-MB-231 cells transfected with the control vector induced fewer lung metastases ( Fig. 4C, Supplementary  Fig. S1C ). Statistic results showed a significant difference between the number of lung colonies derived from miR-200a-overexpressing MDA-MB-231 cells and control cells (Fig. 4D ). In addition, we introduced a construct expressing YAP1 into miR-200a stably expressing cell line of MDA-MB-231. The restoration of YAP1 expression in the stable cell line was confirmed by western blot (supplementary Fig.S4C ). The tail vein injection study showed that restoration of YAP1 could significantly reverse the metastasis promotion imposed by miR-200a ( Fig.4C, D) . Collectively, the data suggest that overexpression of miR-200a or silencing of YAP1 may promote breast cancer cells evasion of anoikis in the circulation, thereby facilitating cancer metastasis.
Inverse correlation between YAP1 and miR-200a expression in breast cancer patients
To address whether the expression of YAP1 is associated with miR-200a in breast cancer patients, miR-200a and YAP1 expression were examined in specimens from 16 breast cancer patients by qRT-PCR and western blotting, respectively. Our investigation showed that the expression of miR-200a was inversely correlated with that of YAP1 in 16 patients, such that YAP1 was expressed at a lower level in specimens overexpressing miR-200a ( Fig. 5A, B) . Moreover, analysis of 40 human breast cancer specimens by qRT-PCR showed a significant negative correlation between YAP1 and miR-200a expression levels by Pearson's correlation analysis (R = -0.562, P = 0.000159, n = 40) ( Fig. 5C ). This data provides further evidence of a functional link between miR-200a and YAP1 in breast cancer. Table 1 . The results showed that no significant correlation between the miR200a expression and age, histological type, size, stage, ER, PR, and Her2. However, we found that miR-200a expression was upregulated by more than 7-fold in lymph node positive specimens compared with lymph node negative specimens. Moreover, in metastasis positive patients the miR-200a expression was 10-fold compared with metastasis negative patients (Table 1) . Thus, these findings suggested that high miR-200a levels were associated with metastatic behavior in breast cancer.
miR-200a is associated with breast cancer metastasis To further understand the relationship between miR-200a and breast cancer metastasis, we performed miR-200a expression analyses on a series of breast tumor samples (n = 110, Cancer Hosipital Fudan University collection). The relationship between the miR-200a expression levels and clinicopathologic parameters of breast cancer was summarized in
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Discussion
In this study, we demonstrate that miR-200a promotes breast cancer metastasis by targeting YAP1. We also proved that upregulation of miR-200a is associated with anoikis resistance. Our data show that miR-200a could reduce the expression of YAP1 by directly binding to the 3'-UTR of YAP1. As a result, caspase-3, p73 and its downstream pro-apoptotic proteins were indirectly inhibited by miR-200a. Silencing YAP1 largely phenocopied miR-200a induced anoikis resistance. In addition, an inverse correlation between miR-200a and YAP1 expression was observed in breast cancer cell lines and tumor specimens. Supplementary Fig.S2 ). These results, together with those previous studies, indicate that overexpression miR-200a may suppress metastasis in breast cancer (12, 13, 23, 34) . However, some evidence showed overexpression of miR-200 in mouse breast cancer cells promoted lung metastasis (15, 16) . Previous identified miR-200a targets were inadequate to explain miR-200a pro-metastatic phenotypes. It is implied miR-200a may be involved in multiple steps of metastasis. A recent paper reported that miR-200s promote 4TO7 mouse carcinoma cells metastatic colonization by directly targeting Sec23a, which mediates secretion of metastasis-suppressive proteins (16, 35) . However, relatively little is known about the role of miR-200a in the translocation of tumor cells. The function of miR-200a in anoikis is still need to be elucidated. Herein we identify a novel role for miR-200a in imbuing human breast cancer cells with anoikis resistance. In vivo mouse model showed antagomiR-200a transfected MCF-7 cells failed to form lung metastasis. Considering tumor metastasis include several steps, and several regulators involve in the phenotype of matastatic potential (14, 36) . The impact of miR-200a expression on the metastasis of breast cancer seems to vary according to histopathologic character, and stage of cancer. Our results provide an explanation for how miR-200a inhibits EMT but promotes lung metastasis. At the initial stage, low levels of miR-200a promote invasion and intravasation. However, once tumor cells enter into the circulation, high miR-200a expression is required for efficient survival and further colonization of secondary organs. Thus, miR-200a may exert its pro-metastatic effects at multiple steps in the metastatic cascade.
The proper execution of apoptosis is a fundamental safeguard against tumorigenesis and metastasis. YAP1 is a well-defined pro-apoptotic transcriptional factor (19) . The inhibition of YAP1 expression greatly reduces detachment-induced apoptosis. Nuclear translocation of YAP1 was inhibited by phosphorylation at the Ser-127 site (37) . Co-transcriptional function of YAP1 was related to this posttranslational modification (38) . Our study has shown that miR-200a directly targets the 3'-UTR of YAP1 to repress the expression of YAP1. These findings suggested that miR-200a negatively regulates YAP1 not only provides an underlying mechanism for the aberrant expression of YAP1 in breast cancer but also demonstrates the importance of Resistance to anoikis, which is a critical step in the metastatic cascade, allows cells to survive within the circulatory and lymphatic systems (35, 39) . Our findings demonstrate that miR-200a promotes tumor cell survival in the circulatory system through confer anoikis resistance, indicating that miR-200a may play roles in the prognosis of cancer. In ovarian cancer, overexpression of the miR-200a correlated with a poor prognosis (40) . Patients with high expression of miR-200a had a shorter median overall survival time compared to those lacking significant miR-200a expression (27.5 months Vs. 61.0 months, respectively) (41) . The present results indicated that miR-200a expression correlates with lymph node metastasis and distant metastasis, which are significant prognosis factors in breast cancer patients. However, the correlation was not observed between miR-200a expression and traditional pathologic markers, such as histological type, hormone receptor status, and TNM stage. One of the reason may be a relatively limited number of patients was used. The other could be the complex function of miR-200a in cancer progression.
In summary, we combined experimental and clinical studies to establish a role for miR-200a in anoikis resistance. We showed that miR-200a promotes anoikis resistance and metastasis via targeting YAP1.
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Figure legends
